Radiotherapy and Chemotherapy

Fundamentals and Pre-clinical Data
  • A. William Blackstock
  • Kevin P. McMullen
Part of the Medical Radiology Radiation Oncology book series (MEDRAD)


Vascular Endothelial Growth Factor Epidermal Growth Factor Receptor Radiat Oncol Biol Phys Hypoxic Cell Tumor Oxygenation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Amellem O, Pettersen EO (1991) Cell inactivation and cell cycle inhibition as induced by extreme hypoxia: the possible role of cell cycle arrest as a protection against hypoxia-induced lethal damage. Cell Prolif 24:127–141PubMedGoogle Scholar
  2. Amorino GP, Mohr PJ et al (2000) Combined effects of the orally active cisplatin analog, JM216, and radiation in antitumor therapy. Cancer Chemother Pharmacol 46:423–426CrossRefPubMedGoogle Scholar
  3. Bandala E, Espinosa M et al (2001) Inhibitor of apoptosis-1 (IAP-1) expression and apoptosis in non-small-cell lung cancer cells exposed to gemcitabine. Biochem Pharmacol 62:13–19CrossRefPubMedGoogle Scholar
  4. Blackstock AW, Lightfoot H et al (2001) Tumor uptake and elimination of 2′,2′-difluoro-2′-deoxycytidine (gemcitabine) after deoxycytidine kinase gene transfer: correlation with in vivo tumor response. Clin Cancer Res 7:3263–3268PubMedGoogle Scholar
  5. Blau M, Altenburger K (1922) Über einige Wirkungen von Strahlen. II. Z Phys 12:315–329Google Scholar
  6. Brown JM (1999) The hypoxic cell: a target for selective cancer therapy-eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res 59:5863–5870PubMedGoogle Scholar
  7. Cappella P, Tomasoni D et al (2001) Cell cycle effects of gemcitabine. Int J Cancer 93:401–408CrossRefPubMedGoogle Scholar
  8. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249–257PubMedGoogle Scholar
  9. Catapano CV, Perrino FW et al (1993) Primer RNA chain termination induced by 9-beta-D-arabinofuranosyl-2-fluoroadenine 5′-triphosphate. A mechanism of DNA synthesis inhibition. J Biol Chem 268:7179–7185PubMedGoogle Scholar
  10. Chen M, Hough AM et al (2000) The role of p53 in gemcitabine-mediated cytotoxicity and radiosensitization. Cancer Chemother Pharmacol 45:369–374CrossRefPubMedGoogle Scholar
  11. Choy H, Rodriguez FF et al (1993) Investigation of taxol as a potential radiation sensitizer. Cancer 71:3774–3778PubMedGoogle Scholar
  12. Crabtree HG, Cramer W (1933) The action of radium on cancer cells I. II. Some factors determining the susceptibility of cancer cells to radium. Proc R Soc Ser B 113:238–250Google Scholar
  13. Dessauer F (1922) Über einige Wirkungen von Strahlen. I. Z Phys 12:38–47Google Scholar
  14. Dewey WC, Ling CC et al (1995) Radiation-induced apoptosis: relevance to radiotherapy. Int J Radiat Oncol Biol Phys 33:781–796CrossRefPubMedGoogle Scholar
  15. Dey S, Spring PM et al (2003) Low-dose fractionated radiation potentiates the effects of Paclitaxel in wild-type and mutant p53 head and neck tumor cell lines. Clin Cancer Res 9:1557–1565PubMedGoogle Scholar
  16. Dolling JA, Boreham DR et al (1998) Modulation of radiation-induced strand break repair by cisplatin in mammalian cells. Int J Radiat Biol 74:61–69PubMedGoogle Scholar
  17. Durand RE (1989) Distribution and activity of antineoplastic drugs in a tumor model. I Natl Cancer Inst 81:146–152Google Scholar
  18. Edelstein MP, Wolfe LA 3rd et al (1996) Potentiation of radiation therapy by vinorelbine (Navelbine) in non-small cell lung cancer. Semin Oncol 23:41–47Google Scholar
  19. Elder DJ, Halton DE et al (1997) Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin Cancer Res 3:1679–1683PubMedGoogle Scholar
  20. Endlich B, Radford IR et al (2000) Computerized video time-lapse microscopy studies of ionizing radiation-induced rapid-interphase and mitosis-related apoptosis in lymphoid cells. Radiat Res 153:36–48PubMedGoogle Scholar
  21. Fontanini G, Vignati S et al (1995) Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype. Eur J Cancer 31A:178–183CrossRefPubMedGoogle Scholar
  22. Forrester HB, Vidair CA et al (1999) Using computerized video time lapse for quantifying cell death of X-irradiated rat embryo cells transfected with c-myc or c-Ha-ras. Cancer Res 59:931–939PubMedGoogle Scholar
  23. Furuta Y, Hall ER et al (1988) Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin. Cancer Res 48:3002–3007PubMedGoogle Scholar
  24. Geard CR, Jones JM et al (1993) Taxol and radiation. J Natil Cancer Inst Monogr 15:89–94Google Scholar
  25. Gessner PK, Cabana BE (1970) A study of the hypnotic and of the toxic effects of chloral hydrate and ethanol. J Pharmacol Exp Ther 174:247–259PubMedGoogle Scholar
  26. Giocanti N, Hennequin C et al (1993) DNA repair and cell cycle interactions in radiation sensitization by the topoisomerase II poison etoposide. Cancer Res 53:2105–2111PubMedGoogle Scholar
  27. Graeber TG, Peterson JF et al (1994) Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol Cell Biol 14:6264–6277PubMedGoogle Scholar
  28. Gray LH, Conger AD et al (1953) Concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br J Radiol 26:638–648PubMedGoogle Scholar
  29. Guo M, Chen C et al (1997) Characterization of radiation-induced apoptosis in rodent cell lines. Radiat Res 147:295–303PubMedGoogle Scholar
  30. Haimovitz-Friedman A (1998) Radiation-induced signal transduction and stress response. Radiat Res 150[Suppl 5]:S102–S108PubMedGoogle Scholar
  31. Hall E (1988) The oxygen effect and reoxygenation in radiobiology for the radiobiologist. Lippincott, Philadelphia, PAGoogle Scholar
  32. Hansen-Algenstaedt N, Stoll BR et al (2000) Tumor oxygenation in hormone-dependent tumors during vascular endothelial growth factor receptor-2 blockade, hormone ablation, and chemotherapy. Cancer Res 60:4556–4560PubMedGoogle Scholar
  33. Heacock CS, Sutherland RM (1986) Induction characteristics of oxygen regulated proteins. Int J Radiat Oncol Biol Phys 12:1287–1290PubMedGoogle Scholar
  34. Herschman HR (1991) Primary response genes induced by growth factors and tumor promoters. Annu Rev Biochem 60:281–319CrossRefPubMedGoogle Scholar
  35. Hockel M, Vaupel P (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93:266–276PubMedGoogle Scholar
  36. Huang NJ, Hittelman WN (1995) Transient inhibition of chromosome damage repair after ionizing radiation by gemcitabine. Proc Am Assoc Cancer Res 36:612Google Scholar
  37. Huang P, Chubb S et al (1990) Termination of DNA synthesis by 9-beta-D-arabinofuranosyl-2-fluoroadenine. A mechanism for cytotoxicity. J Biol Chem 265:16617–16625PubMedGoogle Scholar
  38. Huang SM, Li J et al (2002) Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa). Cancer Res 62:4300–4306PubMedGoogle Scholar
  39. Hughes CS, Shen JW et al (1989) Resistance to etoposide induced by three glucose-regulated stresses in Chinese hamster ovary cells. Cancer Res 49:4452–4454PubMedGoogle Scholar
  40. Jacobson BS (1957) Evidence for recovery from X-ray damage in Chlamydomonas. Radiat Res 7:394–406PubMedGoogle Scholar
  41. Jung C, Motwani M et al (2003) The cyclin-dependent kinase inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis in colon and gastric cancer cells. Clin Cancer Res 9:6052–6061PubMedGoogle Scholar
  42. Kerr DJ, Kaye SB (1987) Aspects of cytotoxic drug penetration, with particular reference to anthracyclines. Cancer Chemother Pharmacol 19:1–5CrossRefPubMedGoogle Scholar
  43. Kerr JF, Wyllie AH et al (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239–257PubMedGoogle Scholar
  44. Klement G, Baruchel S et al (2000) Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity. J Clin Invest 105:R15–R24PubMedGoogle Scholar
  45. Kovacs MS, Hocking DJ et al (1999) Cisplatin anti-tumour potentiation by tirapazamine results from a hypoxia-dependent cellular sensitization to cisplatin. Br J Cancer 80:1245–1251CrossRefPubMedGoogle Scholar
  46. Kozin SV, Boucher Y et al (2001) Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts. Cancer Res 61:39–44PubMedGoogle Scholar
  47. Lawrence TS, Chang E. Y et al (1997) Delayed radiosensitization of human colon carcinoma cells after a brief exposure to 2′,2′-difluoro-2′-deoxycytidine (Gemcitabine). Clin Cancer Res 3:777–782PubMedGoogle Scholar
  48. Lawrence TS, Eisbruch A et al (1999) Radiosensitization by gemcitabine. Oncology (Huntingt) 13:55–60Google Scholar
  49. Lawrence TS, Davis MA et al (2001) The role of apoptosis in 2′,2′-difluoro-2′-deoxycytidine (gemcitabine)-mediated radiosensitization. Clin Cancer Res 7:314–319PubMedGoogle Scholar
  50. Lea DE (1955) Actions of radiations on living cells. Cambridge University Press, LondonGoogle Scholar
  51. Lee CG, Heijn M et al (2000) Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions. Cancer Res 60:5565–5570PubMedGoogle Scholar
  52. Liu XH, Yao S et al (1998) NS398, a selective cyclooxygenase-2 inhibitor, induces apoptosis and down-regulates bcl-2 expression in LNCaP cells. Cancer Res 58:4245–4249PubMedGoogle Scholar
  53. Loewe S (1953) The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 3:285–290PubMedGoogle Scholar
  54. Loewe S (1957) Antagonism and antagonists. Pharmacol Rev 9:237–242PubMedGoogle Scholar
  55. MacRae R, Shyr Y et al (2002) Declining hemoglobin during chemoradiotherapy for locally advanced non-small cell lung cancer is significant. Radiother Oncol 64:37–40PubMedGoogle Scholar
  56. Maity A, McKenna WG et al (1994) The molecular basis for cell cycle delays following ionizing radiation: a review. Radiother Oncol 31:1–13CrossRefPubMedGoogle Scholar
  57. Mason KA, Milas L, Hunter NR, Elshaikh M, Buchmiller L, Kishi K, Hittelman K, Ang KK (1999) Maximizing therapeutic gain with gemcitabine and fractionated radiation. Int J Radiat Oncol Biol Phys. Jul 15;44(5):1125–35CrossRefPubMedGoogle Scholar
  58. Mcgrath R, Williams R (1966) Reconstruction in vivo of irradiated Escherichia coli deoxyribonucleic Acid; the rejoining of broken pieces. Nature 212:534–535PubMedGoogle Scholar
  59. Merlin T, Brandner G et al (1998) Cell cycle arrest in ovarian cancer cell lines does not depend on p53 status upon treatment with cytostatic drugs. Int J Oncol 13:1007–1016PubMedGoogle Scholar
  60. Milas L(2003) Cyclooxygenase-2 (COX-2) enzyme inhibitors and radiotherapy: preclinical basis. Am J Clin Oncol 26:S66–S69Google Scholar
  61. Milas L, Furuta Y et al (1990) Dependence of indomethacin-induced potentiation of murine tumor radioresponse on tumor host immunocompetence. Cancer Res 50:4473–4477PubMedGoogle Scholar
  62. Milas L, Kishi K et al (1999) Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme. J Natl Cancer Inst 91:1501–1504CrossRefPubMedGoogle Scholar
  63. Murata R, Nishimura Y et al (1997) An antiangiogenic agent (TNP-470) inhibited reoxygenation during fractionated radiotherapy of murine mammary carcinoma. Int J Radiat Oncol Biol Phys 37:1107–1113CrossRefPubMedGoogle Scholar
  64. Murphy BJ, Laderoute KR et al (1994) Metallothionein IIA is up-regulated by hypoxia in human A431 squamous carcinoma cells. Cancer Res 54:5808–5810PubMedGoogle Scholar
  65. Nabid A, Choy H et al (2002) Encouraging survival results with RSR13 and concurrent radiation therapy: interim analysis of a phase II study for locally advanced unresectable non-small cell lung cancer. Proc Am Soc Clin Oncol 21:1236Google Scholar
  66. Omura M, Torigoe S et al (1997) SN-38, a metabolite of the camptothecin derivative CPT-11, potentiates the cytotoxic effect of radiation in human colon adenocarcinoma cells grown as spheroids. Radiother Oncol 43:197–201CrossRefPubMedGoogle Scholar
  67. Pallavicini MG, Lalande ME et al (1979) Cell cycle distribution of chronically hypoxic cells and determination of the clonogenic potential of cells accumulated in G2 + M phases after irradiation of a solid tumor in vivo. Cancer Res 39:1891–1897PubMedGoogle Scholar
  68. Pauwels B, Korst AE et al (2003) Cell cycle effect of gemcitabine and its role in the radiosensitizing mechanism in vitro. Int J Radiat Oncol Biol Phys 57:1075–1083CrossRefPubMedGoogle Scholar
  69. Prewett M, Huber J et al (1999) Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res 59:5209–5218PubMedGoogle Scholar
  70. Price BD, Calderwood SK (1992) Gadd45 and Gadd153 messenger RNA levels are increased during hypoxia and after exposure of cells to agents which elevate the levels of the glucose-regulated proteins. Cancer Res 52:3814–3817PubMedGoogle Scholar
  71. Pyo H, Choy H et al (2001) A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2. Clin Cancer Res 7:2998–3005PubMedGoogle Scholar
  72. Raben D, Helfrich BA et al (2002) ZD1839, a selective epidermal growth factor receptor tyrosine kinase inhibitor, alone and in combination with radiation and chemotherapy as a new therapeutic strategy in non-small cell lung cancer. Semin Oncol 29 [Suppl 4]:37–46CrossRefPubMedGoogle Scholar
  73. Rice GC, Hoy C et al (1986) Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells. Proc Natl Acad Sci USA 83:5978–5982PubMedGoogle Scholar
  74. Richmond RC, Mahtani HK (1991) An interrelatedness of the potentiation of radiation-induced bacterial cell killing by cisplatin and binuclear rhodium carboxylates. Radiat Res 127:36–44PubMedGoogle Scholar
  75. Rusch V, Baselga J et al (1993) Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res 53[Suppl 10]:2379–2385PubMedGoogle Scholar
  76. Rusch V, Klimstra D et al (1997) Overexpression of the epidermal growth factor receptor and its ligand transforming growth factor alpha is frequent in resectable non-small cell lung cancer but does not predict tumor progression. Clin Cancer Res 3:515–522PubMedGoogle Scholar
  77. Sciandra JJ, Subjeck JR et al (1984) Induction of glucose-regulated proteins during anaerobic exposure and of heat-shock proteins after reoxygenation. Proc Natl Acad Sci USA 81:4843–4847PubMedGoogle Scholar
  78. Sheng H, Shao J et al (1997) Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 99:2254–2259PubMedGoogle Scholar
  79. Shewach DS, Lawrence TS (1996) Gemcitabine and radiosensitization in human tumor cells. Invest New Drugs 14:257–263PubMedGoogle Scholar
  80. Strasser A, Harris AW et al (1994) DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2. Cell 79:329–339CrossRefPubMedGoogle Scholar
  81. Taketo MM (1998) Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J Natl Cancer Inst 90:1609–1620CrossRefPubMedGoogle Scholar
  82. Tallarida RJ (2001) Drug synergism: its detection and applications. Pharmacology 298:865–872Google Scholar
  83. Tallarida RJ, Porreca F, Cowan A (1989) Statistical analysis of drug-drug and site-site interactions with isobolograms. Life Sci 45:947–961CrossRefPubMedGoogle Scholar
  84. Tannock I, Guttman P (1981) Response of Chinese hamster ovary cells to anticancer drugs under aerobic and hypoxic conditions. Br J Cancer 43:245–248PubMedGoogle Scholar
  85. Teicher BA, Holden SA et al (1990) Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma. Cancer Res 50:3339–3344PubMedGoogle Scholar
  86. Teicher BA, Ara G et al (1997) PEG-hemoglobin: effects on tumor oxygenation and response to chemotherapy. In Vivo 11:301–311PubMedGoogle Scholar
  87. Terasima T, Tolmach L (1963) X-ray sensitivity and DNA synthesis in synchronous populations. Science 140:490–492PubMedGoogle Scholar
  88. Tolis C, Peters GJ et al (1999) Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines. Eur J Cancer 35:796–807CrossRefPubMedGoogle Scholar
  89. Tseng WC, Derse D et al (1982) In vitro biological activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells. Mol Pharmacol 21:474–477PubMedGoogle Scholar
  90. Vidair CA, Chen CH et al (1996) Apoptosis induced by X-irradiation of rec-myc cells is postmitotic and not predicted by the time after irradiation or behavior of sister cells. Cancer Res 56:4116–4118PubMedGoogle Scholar
  91. Ward JF (1994) The complexity of DNA damage: relevance to biological consequences. Int J Radiat Biol 66:427–432PubMedGoogle Scholar
  92. Williams CS, Mann M et al (1999) The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 18:7908–7916CrossRefPubMedGoogle Scholar
  93. Williams KJ, Telfer BA et al (2002) ZD1839 ('Iressa'), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model. Br J Cancer 86:1157–1161CrossRefPubMedGoogle Scholar
  94. Yang LX, Douple EB et al (1995) Carboplatin enhances the production and persistence of radiation-induced DNA single-strand breaks. Radiat Res 143:302–308PubMedGoogle Scholar
  95. Yang LX, Douple EB et al (1995) Irradiation enhances cellular uptake of carboplatin. Int J Radiat Oncol Biol Phys 33:641–646CrossRefPubMedGoogle Scholar
  96. Yang SW, Huang P et al (1992) Dual mode of inhibition of purified DNA ligase I from human cells by 9-beta-D-arabinofuranosyl-2-fluoroadenine triphosphate. J Biol Chem 267:2345–2349PubMedGoogle Scholar
  97. Zhang M, Boyer M et al (2004) Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non-small-cell lung cancer cells. Int J Radiat Oncol Biol Phys 58:353–360CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • A. William Blackstock
    • 1
  • Kevin P. McMullen
    • 2
  1. 1.Department of Radiation Oncology/Radiation BiologyComprehensive Cancer Center of Wake Forest UniversityWinston SalemUSA
  2. 2.Department of Radiation OncologyComprehensive Cancer Center of Wake Forest UniversityWinston SalemUSA

Personalised recommendations